A Phase 2 Study to Evaluate the Efficacy and Safety of Simtuzumab in Adult Subjects with Primary, Post Polycythemia Vera (PV) or Post Essential Thrombocythemia (ET) Myelofibrosis Verstovsek, S., Savona, M. R., Mesa, R. A., Oh, S., Dong, H., Thai, D., Gotlib, J. AMER SOC HEMATOLOGY. 2015

View details for Web of Science ID 000368020103005